No events are scheduled in this topic at this time. Click the RSS icon above and bookmark our RSS feed to learn about future events.
Friday, October 7, 2016 | 9:00 AM - 5:00 PM
Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.
Tuesday, June 21, 2016 | 8:30 AM - 5:00 PM
Keynote Speaker: Sharon Inouye (Harvard Medical School)
This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.
Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM
Moderator: Claudia Wallis (Scientific American Mind)
Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD
1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
Featuring: Sharon Inouye, MD, MPH (Harvard Medical School)
Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia for many patients, a risk that is poorly understood and often under-recognized in the clinic. With numerous factors—including age—contributing to each patient's level of risk, what are the challenges and opportunities to create biomarkers and therapeutics for those who are most vulnerable?
Edited by Annals of the New York Academy of Sciences
This Annals issue presents papers from a three-part series, in collaboration with the Nour Foundation, on the science of happiness, morality, and wisdom.
Edited by Hui B. Sun
(Albert Einstein College of Medicine)
The papers in this Annals issue explore novel musculoskeletal repair and regeneration strategies that could be translated to clinical treatment of rotator cuff injuries, osteoarthritis, and other bone and cartilage diseases.
Edited by Xavier Rodó
(Catalan Institute for Climate Sciences)
This Annals issue discusses the latest research on the effects of climate and environmental changes on human health, including on the transmission of infectious diseases and the epidemiology of noncommunicable diseases.